Skip to main content
Premium Trial:

Request an Annual Quote

Swift Biosciences Normalase Amplicon Panel SARS-CoV-2 Kit

Swift Biosciences has released a new sample preparation kit for low viral titer SARS-CoV-2 specimens.

The Swift Normalase Amplicon Panel SARS-CoV-2 kit targets the full coronavirus genome in a single-tube reaction. The two-round PCR workflow takes as little as two hours and produces multiplexed, sequencing-ready libraries. The kit is intended for use in research or pathogen surveillance.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.